Tris Pharma, Inc.
Tris Pharma, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in developing innovative drug delivery systems, particularly in the areas of paediatrics and chronic pain management. Tris Pharma focuses on creating unique formulations that enhance patient compliance and therapeutic outcomes, setting it apart from competitors. With a strong presence in the US market, Tris Pharma has achieved significant milestones, including the successful launch of several proprietary products that address unmet medical needs. The company’s commitment to research and development, coupled with its expertise in complex formulations, has solidified its position as a trusted partner in the pharmaceutical landscape.
DitchCarbon Score
How does Tris Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tris Pharma, Inc.'s score of 13 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tris Pharma, Inc.'s reported carbon emissions
Tris Pharma, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and reducing their carbon footprints. While Tris Pharma has not disclosed specific initiatives or targets, it is essential for organisations in this sector to align with industry standards and best practices in climate action. This includes setting science-based targets and committing to transparency in emissions reporting to contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tris Pharma, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
